DOI 10.1016/j.mtbio.2025.102068
ROS-scavenging hydrogen nanotherapy simultaneously targets inflammation and pain in rheumatoid arthritis.
Аннотация
Relieving pain while treating rheumatoid arthritis (RA) is a pressing clinical need to improve satisfaction of patients, which has not received the due attention and solution. Herein, we propose a strategy to kill two birds with one stone, for which we emphasize synergetic therapeutic outcome of analgesia and inhibiting RA progression through introducing hydrogen nanogenerator to scavenge reactive oxygen species (ROS) at lesion locations. This system exhibited efficient ROS scavenging and reducing apoptosis of C17.2 cells. In a complete Freund's Adjuvant-induced RA mouse model, this controlled hydrogen release behavior significantly downregulated pro-inflammatory mediators, protecting chondrocytes from apoptosis and preventing cartilage degradation. Furthermore, hydrogen therapy could effectively restrain the release of inflammatory factors and central sensitization by alleviating mitochondrial dysfunction in peripheral neurons and inhibit NF-κB pathway. Targeting ROS, this approach represents a significant advancement in RA management, offering superior efficacy against nociplastic pain compared to conventional analgesic therapies, providing a novel treatment mode of synergistic anti-inflammatory therapy and pain management.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.